Figures & data
Figure 1. Effects of iloprost on caspases-3, -8, and -9 in kidney as a distant organ. Treatment of iloprost in I/R + iloprost subjects decreased the caspase-3, -8, and -9 enzyme activities as compared with both the ischemia and the I/R groups. Even more, iloprost (10 μg kg–1) treatment in I/R + iloprost subjects decreased the caspase-3 enzyme activity as compared with the sham group. Values are expressed as means ± SEM.
Note: p < 0.05 was considered to be significant. *Significantly different from sham, **significantly different from ischemia, ***significantly different from I/R, and #significantly different from iloprost.
![Figure 1. Effects of iloprost on caspases-3, -8, and -9 in kidney as a distant organ. Treatment of iloprost in I/R + iloprost subjects decreased the caspase-3, -8, and -9 enzyme activities as compared with both the ischemia and the I/R groups. Even more, iloprost (10 μg kg–1) treatment in I/R + iloprost subjects decreased the caspase-3 enzyme activity as compared with the sham group. Values are expressed as means ± SEM.Note: p < 0.05 was considered to be significant. *Significantly different from sham, **significantly different from ischemia, ***significantly different from I/R, and #significantly different from iloprost.](/cms/asset/15a21079-c79b-4bc2-8fb0-012f5a2db09e/irnf_a_633446_f0001_b.gif)